Soysal, T., Eskazan, A. E., Serin, I., Sadri, S., Keskin, D., Ozgur Yurttas, N., . . . Aydin, Y. (2019). The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations. Clinical Lymphoma, Myeloma and Leukemia, 19(7), e377. https://doi.org/10.1016/j.clml.2019.03.028

Soysal, Teoman, et al. "The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations." Clinical Lymphoma, Myeloma and Leukemia 19, no. 7 (2019): e377. https://doi.org/10.1016/j.clml.2019.03.028.

Soysal, Teoman, et al. "The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations." Clinical Lymphoma, Myeloma and Leukemia, vol. 19, no. 7, 2019, p. e377, https://doi.org/10.1016/j.clml.2019.03.028.